Literature DB >> 12473777

Impaired renal function in progressive multiple sclerosis.

P A Calabresi1, H Austin, M K Racke, A Goodman, P Choyke, H Maloni, H F McFarland.   

Abstract

The authors analyzed renal function in 25 patients with progressive MS. The mean glomerular filtration rate (GFR) was 92 mL/min/1.73 m(2), compared to the predicted GFR of 110 (p < 0.001). Nine of the 25 (36%) patients had abnormally low GFR (<90). The mean serum creatinine for patients with MS was lower than predicted normal values and poorly estimated GFR using standard equations. These data document impaired renal function in patients with progressive MS and have implications for treatment of these patients with potentially nephrotoxic drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473777     DOI: 10.1212/01.wnl.0000036618.68674.7a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Takahisa Masaki; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2007-01-02       Impact factor: 3.478

2.  An Apparent Correlation Between Central Nervous System and Kidney's Erythropoietin and TNF Alpha Expression at Peak Experimental Autoimmune Encephalomyelitis Disease.

Authors:  Sahar Rostami Mansoor; Abdolamir Allameh; Hadi Parsian
Journal:  J Mol Neurosci       Date:  2018-06-06       Impact factor: 3.444

3.  Contributors to Serum NfL Levels in People without Neurologic Disease.

Authors:  Kathryn C Fitzgerald; Elias S Sotirchos; Matthew D Smith; Hannah-Noelle Lord; Anna DuVal; Ellen M Mowry; Peter A Calabresi
Journal:  Ann Neurol       Date:  2022-07-13       Impact factor: 11.274

4.  Cross-reactive myelin antibody induces renal pathology.

Authors:  Lisa K Peterson; Takahisa Masaki; Steven R Wheelwright; Ikuo Tsunoda; Robert S Fujinami
Journal:  Autoimmunity       Date:  2008-11       Impact factor: 2.815

5.  Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.

Authors:  Michele Jara; Matthew F Sidovar; Herbert R Henney
Journal:  Ther Clin Risk Manag       Date:  2014-12-16       Impact factor: 2.423

6.  Experimental autoimmune encephalomyelitis (EAE) up-regulates the mitochondrial activity and manganese superoxide dismutase (MnSOD) in the mouse renal cortex.

Authors:  Balamurugan Packialakshmi; Xiaoming Zhou
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

Review 7.  Cross-talks between the kidneys and the central nervous system in multiple sclerosis.

Authors:  Sahar Rostami; Mohammad-Sajad Emami-Aleagha; Maryam Ghasemi-Kasman; Abdolamir Allameh
Journal:  Caspian J Intern Med       Date:  2018

8.  Effects of cigarette smoke exposure on a mouse model of multiple sclerosis.

Authors:  Jenny Ho; Kyoko Koshibu; Wenhao Xia; Karsta Luettich; Athanasios Kondylis; Llenalia Garcia; Blaine Phillips; Manuel Peitsch; Julia Hoeng
Journal:  Toxicol Rep       Date:  2022-03-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.